PROCTER & GAMBLE HEALTH | HINDUSTAN BIOSCIE | PROCTER & GAMBLE HEALTH/ HINDUSTAN BIOSCIE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 311.2 | 11.1% | View Chart |
P/BV | x | 10.6 | 11.7 | 90.4% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH HINDUSTAN BIOSCIE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
HINDUSTAN BIOSCIE Mar-23 |
PROCTER & GAMBLE HEALTH/ HINDUSTAN BIOSCIE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 6 | 95,814.3% | |
Low | Rs | 3,883 | 3 | 120,216.7% | |
Sales per share (Unadj.) | Rs | 740.7 | 0.9 | 82,348.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | 0 | -354,227.0% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 0 | -454,404.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 0.7 | 61,420.5% | |
Shares outstanding (eoy) | m | 16.60 | 10.25 | 162.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 4.9 | 127.2% | |
Avg P/E ratio | x | 33.5 | -111.7 | -29.9% | |
P/CF ratio (eoy) | x | 29.8 | -130.2 | -22.9% | |
Price / Book Value ratio | x | 10.3 | 6.1 | 170.4% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 45 | 169,608.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 2 | 115,178.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 9 | 133,364.4% | |
Other income | Rs m | 184 | 0 | - | |
Total revenues | Rs m | 12,480 | 9 | 135,359.0% | |
Gross profit | Rs m | 3,247 | 0 | -1,159,571.4% | |
Depreciation | Rs m | 281 | 0 | 468,333.3% | |
Interest | Rs m | 8 | 0 | 19,250.0% | |
Profit before tax | Rs m | 3,142 | 0 | -826,842.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 0 | 2,824,333.3% | |
Profit after tax | Rs m | 2,295 | 0 | -573,675.0% | |
Gross profit margin | % | 26.4 | -3.1 | -863.6% | |
Effective tax rate | % | 27.0 | -6.6 | -409.9% | |
Net profit margin | % | 18.7 | -4.4 | -425.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 9 | 136,195.3% | |
Current liabilities | Rs m | 6,791 | 14 | 47,890.0% | |
Net working cap to sales | % | 40.0 | -60.6 | -66.1% | |
Current ratio | x | 1.7 | 0.6 | 284.4% | |
Inventory Days | Days | 263 | 946 | 27.8% | |
Debtors Days | Days | 343 | 179,564,165 | 0.0% | |
Net fixed assets | Rs m | 10,617 | 24 | 43,799.1% | |
Share capital | Rs m | 166 | 21 | 809.8% | |
"Free" reserves | Rs m | 7,265 | -13 | -55,709.4% | |
Net worth | Rs m | 7,431 | 7 | 99,471.2% | |
Long term debt | Rs m | 0 | 11 | 0.0% | |
Total assets | Rs m | 22,330 | 33 | 67,995.4% | |
Interest coverage | x | 409.1 | -8.5 | -4,812.4% | |
Debt to equity ratio | x | 0 | 1.5 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.3 | 196.1% | |
Return on assets | % | 10.3 | -1.1 | -931.5% | |
Return on equity | % | 30.9 | -5.4 | -570.3% | |
Return on capital | % | 42.4 | -1.8 | -2,340.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 6 | 24,960.8% | |
Fx outflow | Rs m | 1,605 | 0 | - | |
Net fx | Rs m | -140 | 6 | -2,388.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -1 | -472,000.0% | |
From Investments | Rs m | -215 | NA | - | |
From Financial Activity | Rs m | -985 | 1 | -196,940.0% | |
Net Cashflow | Rs m | 1,160 | 0 | - |
Indian Promoters | % | 0.0 | 12.2 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 87.8 | 54.9% | |
Shareholders | 56,778 | 10,921 | 519.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | HINDUSTAN BIOSCIE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -3.41% | 0.45% |
1-Month | -1.15% | 12.73% | 2.55% |
1-Year | 0.73% | 1.55% | 56.14% |
3-Year CAGR | -8.76% | 38.06% | 15.22% |
5-Year CAGR | 4.97% | 55.33% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the HINDUSTAN BIOSCIE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of HINDUSTAN BIOSCIE the stake stands at 12.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of HINDUSTAN BIOSCIE.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
HINDUSTAN BIOSCIE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of HINDUSTAN BIOSCIE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.